Company News in the Life Science Industry

»

Reset 

Steeper Group Secure Landmark Deal and Add to Upper Limb Prosthetics Portfolio

LEEDS, England, June 2, 2020 /PRNewswire/ -- Leeds (UK) based prosthetics manufacturer, Steeper Group, has completed acquisition of the Espire Elbow prostheses range from US based College Park Industries.

Read more ››
By: PR Newswire Association LLC. - 02 Jun 2020

Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology

SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ -- Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement with the University of Illinois at Urbana-Champaign for an exclusive global patent license to a novel... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020

AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer's Disease

MANCHESTER, England, June 2, 2020 /PRNewswire/ -- The therapeutics biotech AstronauTx announces a partnership with Concept Life Sciences, Contract Research Organisation, to progress the identification of novel therapies for Alzheimer's disease. The alliance will focus on identifying small molecule... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020

Cannabis Pharmaceuticals Market Size Worth $5.8 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, June 2, 2020 /PRNewswire/ -- The global cannabis... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020

Dental Drug Market Analysis and Industry Insights Report, 2028 | Market Growth to be Motivated by Increasing Alertness Towards Oral Cleanliness and Dental Care: Radiant Insights, Inc.

SAN FRANCISCO, June 2, 2020 /PRNewswire/ --Global Dental Drug Market is estimated to... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Radiant Insights, Inc

Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndro

HOUSTON, June 2, 2020 /PRNewswire/ -- Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells)... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Cellenkos Inc.

BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020

NEW YORK, June 2, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today an update on the Company's Phase 3 pivotal trial investigating NurOwn(® )in ALS. The Company continues to... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  BrainStorm Cell Therapeutics Inc.

Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines

WOBURN, Mass., June 2, 2020 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focused on delivering safe treatments to improve surgical efficacy, today announced growing enthusiasm among physicians for its Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Intrinsic LifeSciences LLC | Intrinsic Therapeutics, Inc.

Cellenkos® Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome

HOUSTON, June 2, 2020 /CNW/ -- Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Cellenkos Inc.

Memgen Announces Research to Be Presented at 2020 American Association of Cancer Research (AACR) Meeting

HOUSTON, June 2, 2020 /PRNewswire/ -- Memgen, a private biotechnology company developing novel treatments for cancer and COVID-19, announced an abstract and upcoming poster presentation at the 2020 American Association of Cancer Research (AACR) Virtual Annual Meeting II on June 22-24, 2020.

Read more ››
By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Memgen, LLC. | Memgen

Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair

SEATTLE, June 2, 2020 /PRNewswire/ -- For men and women in the United States, hair loss is an increasing concern. Thinning hair, male pattern baldness, and aging all contribute to losing hair. Many think that the only effective treatment for hair loss is hair transplant surgery. However, Dr.... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020

Insightful Science Acquires nQuery, Builds on Portfolio of Category-Leading Scientific Software Solutions

SAN DIEGO, June 2, 2020 /PRNewswire/ -- Insightful Science announced today it has acquired Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 02 Jun 2020
Related companies:  Allogene Therapeutics, Inc.

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

Read more ››
By: GlobenewsWire - 02 Jun 2020
Related companies:  Adaptimmune Therapeutics plc.

WILDFLOWER REPORTS REVENUES OF $5.3 MILLION

Read more ››
By: GlobenewsWire - 02 Jun 2020

FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer

Read more ››
By: GlobenewsWire - 02 Jun 2020
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

Read more ››
By: GlobenewsWire - 02 Jun 2020
Related companies:  MeMed Diagnostics Ltd.

Santhera Announces Completion of ReveraGen’s Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy

Read more ››
By: GlobenewsWire - 02 Jun 2020

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

Read more ››
By: GlobenewsWire - 02 Jun 2020

Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial

STOCKHOLM, June 2, 2020 /PRNewswire/ -- Oncoinvent AS, a clinical stage radiopharmaceutical company developing novel radioisotope-based therapies to provide new therapeutic options for cancer patients, today announced that the first patient has been dosed in the phase 1, first-in-human clinical... Read more ››

By: PR Newswire Association LLC. - 02 Jun 2020
Related companies:  Oncoinvent AS
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies